# Evidence Digest: Evidence-based Management of Pediatric Acute Otitis Media
Clinical bottom line
Acute otitis media (AOM) is a common pediatric condition characterized by the inflammation of the middle ear, often leading to pain and fever. Evidence suggests that management strategies should be tailored to the severity of symptoms, age of the child, and the presence of bilateral disease. Antibiotic therapy is indicated in certain cases, particularly in children under 2 years with bilateral AOM or those with severe symptoms. However, watchful waiting is a viable option for many children, especially those with mild symptoms.What the evidence shows
A systematic review by Rosenfeld et al. (2016) highlights that the majority of AOM cases are viral in origin, and many resolve spontaneously without antibiotics. The review emphasizes that antibiotics can reduce pain and the duration of symptoms in certain populations but may not be necessary for all children with AOM (PMID: 27926720).A study by Hoberman et al. (2011) found that children aged 6 to 23 months with non-severe AOM could be safely managed with a watchful waiting approach, with only 25% requiring antibiotics within 48 hours (PMID: 21727240). This suggests that careful observation can be an effective strategy, reducing unnecessary antibiotic exposure and the risk of resistance.
In contrast, a meta-analysis by Venekamp et al. (2015) indicated that antibiotics are beneficial in reducing the risk of treatment failure and pain in children with severe AOM symptoms (PMID: 26214454). The analysis showed that antibiotics led to a 20% reduction in treatment failure compared to placebo, particularly in children with severe symptoms or those under 2 years of age.
Caveats and uncertainty
While the evidence supports both watchful waiting and antibiotic treatment in specific populations, there are limitations to consider. The studies often involve varying definitions of "severe" symptoms and different antibiotic regimens, which may affect generalizability. Additionally, the risk of complications, such as recurrent AOM or hearing loss, remains a concern, particularly in high-risk populations. The decision-making process should involve shared decision-making with caregivers, weighing the benefits and risks of antibiotic use.How this may change practice
The evidence presented suggests a shift towards more conservative management of AOM in pediatric populations. Clinicians may consider implementing a watchful waiting approach for children with non-severe symptoms, reserving antibiotics for those with significant discomfort or at higher risk for complications. This could lead to a decrease in unnecessary antibiotic prescriptions, thereby addressing the growing concern of antibiotic resistance.Furthermore, the emphasis on shared decision-making may enhance caregiver understanding and satisfaction with the management plan, fostering a collaborative approach to care. Continued education on the appropriate use of antibiotics in AOM management will be essential in changing practice patterns.